New drug combo tested for Tough-to-Treat blood cancer
NCT ID NCT04661137
Summary
This study is testing whether adding a drug called selinexor to existing multiple myeloma treatments can help patients whose cancer has returned or stopped responding to their current therapy. The trial involves 96 adults with multiple myeloma that has progressed despite treatment with specific drugs. Participants will receive different drug combinations based on which treatment their cancer previously stopped responding to, with the goal of controlling the disease and extending survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
John Theurer Cancer Center
Hackensack, New Jersey, 07601, United States
-
Lombardi Comprehensive Cancer Center
Washington D.C., District of Columbia, 20007, United States
Conditions
Explore the condition pages connected to this study.